Fresenius Medical (Germany) Today
FME Stock | 42.25 0.81 1.95% |
Performance13 of 100
| Odds Of DistressLess than 9
|
Fresenius Medical is selling for under 42.25 as of the 24th of November 2024; that is 1.95% up since the beginning of the trading day. The stock's last reported lowest price was 41.61. Fresenius Medical has less than a 9 % chance of experiencing financial distress in the next few years and had a good performance during the last 90 days. Equity ratings for Fresenius Medical Care are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of October 2024 and ending today, the 24th of November 2024. Click here to learn more.
Moving against Fresenius Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Fresenius Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Fresenius Medical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Fresenius Medical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Chief CEO | Helen Giza |
Business Concentration | Medical Care Facilities, Healthcare (View all Sectors) |
Fresenius Medical Care (FME) is traded on XETRA Stock Exchange in Germany and employs 128,044 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 10.4 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Fresenius Medical's market, we take the total number of its shares issued and multiply it by Fresenius Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Fresenius Medical Care operates under Healthcare sector and is part of Medical Care Facilities industry. The entity has 293.41 M outstanding shares.
Fresenius Medical Care has accumulated about 556.52 M in cash with 2.17 B of positive cash flow from operations.
Check Fresenius Medical Probability Of Bankruptcy
Ownership AllocationFresenius Medical holds a total of 293.41 Million outstanding shares. Fresenius Medical Care retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Fresenius Ownership Details
Fresenius Medical Care Risk Profiles
Although Fresenius Medical's alpha and beta are two of the key measurements used to evaluate Fresenius Medical's performance over the market, the standard measures of volatility play an important role as well.
Mean Deviation | 1.25 | |||
Semi Deviation | 1.46 | |||
Standard Deviation | 1.77 | |||
Variance | 3.12 |
Fresenius Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Fresenius Medical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Fundamentals Comparison Now
Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities |
All Next | Launch Module |
Fresenius Medical Corporate Management
Elected by the shareholders, the Fresenius Medical's board of directors comprises two types of representatives: Fresenius Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Fresenius. The board's role is to monitor Fresenius Medical's management team and ensure that shareholders' interests are well served. Fresenius Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Fresenius Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Borries Muller | VP Communications | Profile | |
Dominik Heger | Strategic Relations | Profile | |
Roberto Fuste | Ex Strategy | Profile | |
William Valle | Management AG | Profile | |
Nwamaka MD | Head Operations | Profile | |
Katarzyna MazurHofsab | Management AG | Profile |
Additional Tools for Fresenius Stock Analysis
When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.